Compile Data Set for Download or QSAR
maximum 50k data
Found 39 Enz. Inhib. hit(s) with all data for entry = 10008
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507666(US11046682, Compound 35)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507684(US11046682, Compound 62)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507678(US11046682, Compound 53)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507677(US11046682, Compound 52)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507676(US11046682, Compound 51)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507675(US11046682, Compound 50)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507674(US11046682, Compound 49)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507673(US11046682, Compound 48)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507672(US11046682, Compound 47)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507671(US11046682, Compound 45)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507670(US11046682, Compound 42)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507669(US11046682, Compound 41)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507667(US11046682, Compound 37)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507665(US11046682, Compound 34)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507663(US11046682, Compound 32)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507658(US11046682, Compound 24)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507657(US11046682, Compound 23)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507649(US11046682, Compound 14)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507652(US11046682, Compound 17)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507653(US11046682, Compound 19)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507654(US11046682, Compound 20)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507656(US11046682, Compound 22)
Affinity DataIC50: <250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507681(US11046682, Compound 58)
Affinity DataIC50:  875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507647(US11046682, Compound 1)
Affinity DataIC50:  875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507661(US11046682, Compound 29)
Affinity DataIC50:  875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507660(US11046682, Compound 28)
Affinity DataIC50:  875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507659(US11046682, Compound 27)
Affinity DataIC50:  875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507680(US11046682, Compound 55)
Affinity DataIC50:  875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507679(US11046682, Compound 54)
Affinity DataIC50:  875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507668(US11046682, Compound 40)
Affinity DataIC50:  875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507655(US11046682, Compound 21)
Affinity DataIC50:  875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507683(US11046682, Compound 61)
Affinity DataIC50:  875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507685(US11046682, Compound 63B:)
Affinity DataIC50:  875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507682(US11046682, Compound 59)
Affinity DataIC50:  875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507651(US11046682, Compound 16)
Affinity DataIC50:  875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507650(US11046682, Compound 15)
Affinity DataIC50:  875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507664(US11046682, Compound 33)
Affinity DataIC50:  875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507648(US11046682, Compound 3)
Affinity DataIC50:  875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM507662(US11046682, Compound 30)
Affinity DataIC50:  875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent